• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by SinoMab BioScience Limited

News headline image
SinoMab BioScience Limited Breakthrough Phase 1b POC Results for SM17 in Atopic Dermatitis
April 09, 2025
From SinoMab BioScience Limited
Via ACN Newswire
News headline image
SinoMab Awarded the "Most Valuable Pharmaceutical and Medical Company" in the Selection of the "7th Hong Kong Golden Stocks Awards"
December 19, 2022
From SinoMab BioScience Limited
Via ACN Newswire
News headline image
IND Application for SinoMab's First-in-Class Asthma Therapeutic Product SM17 Approved by FDA
March 14, 2022
From SinoMab BioScience Limited
Via ACN Newswire
News headline image
IND Application for SinoMab's First-in-Class Asthma Therapeutic Product SM17 Accepted by FDA
February 17, 2022
From SinoMab BioScience Limited
Via ACN Newswire
News headline image
SinoMab Announces IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE
February 07, 2022
From SinoMab BioScience Limited
Via ACN Newswire
News headline image
SinoMab Awared the "Best Small and Mid-Cap Company" and "Best CEO" in the Selection of the "6th Hong Kong Golden Stocks Awards" and the "Listed Company with the Most Growth Potential" in the Selection of "2021 Sina Finance Golden Unicorn Best Hong Kong
January 11, 2022
From SinoMab BioScience Limited
Via ACN Newswire
News headline image
SinoMab Announces the Completion of Enrollment in Phase III Clinical Trial in China for its Flagship Product, SM03
November 30, 2021
From SinoMab BioScience Limited
Via ACN Newswire
News headline image
SinoMab Was Invited to Attend the Inaugural Asia Summit on Global Health
November 26, 2021
From SinoMab BioScience Limited
Via ACN Newswire
News headline image
SinoMab, Sinovent and Everest Medicines Announce Licensing Agreement for Global Development and Commercialization of A Next-Generation BTK Inhibitor in Renal Diseases
September 17, 2021
From SinoMab BioScience Limited
Via ACN Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap